1. Food and Drugs Association (2020) Drug approvals and databases. p. 1. Available from: https://www.fda.gov/drugs/development-approval-process-drugs/drug-approvals-and-databases
2. Jackson K, Nahata MC (2017) Rising cost of anticancer medications in the United States. Ann Pharmacother 51(8):706–10. Available from: https://doi.org/10.1177/1060028017702406
3. Xu K, Soucat A, Kutzin J, Brindley C (2018) Public spending on health : a closer look at global trends. Geneva. Available from: https://apps.who.int/iris/bitstream/handle/10665/276728/WHO-HIS-HGF-HF-WorkingPaper-18.3-eng.pdf?ua=1
4. Belloni A, Morgan D (2018) Pharmaceutical expenditure and policies : past trends and future challenges. OECD (87):0–75
5. Martinalbo J, Bowen D, Camarero J et al (2016) Early market access of cancer drugs in the EU. Ann Oncol 27(1):96–105. Available from: https://doi.org/10.1093/annonc/mdv506